Literature DB >> 9407154

Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis.

J E Koehler1, M A Sanchez, C S Garrido, M J Whitfeld, F M Chen, T G Berger, M C Rodriguez-Barradas, P E LeBoit, J W Tappero.   

Abstract

BACKGROUND: Bacillary angiomatosis and bacillary peliosis are vascular proliferative manifestations of infection with species of the genus bartonella that occur predominantly in patients infected with the human immunodeficiency virus. Two species, B. henselae and B. quintana, have been associated with bacillary angiomatosis, but culture and speciation are difficult, and there has been little systematic evaluation of the species-specific disease characteristics. We studied 49 patients seen over eight years who were infected with bartonella species identified by molecular techniques and who had clinical lesions consistent with bacillary angiomatosis-peliosis.
METHODS: In this case-control study, a standardized questionnaire about exposures was administered to patients with bacillary angiomatosis-peliosis and to 96 matched controls. The infecting bartonella species were determined by molecular techniques.
RESULTS: Of the 49 patients with bacillary angiomatosis-peliosis, 26 (53 percent) were infected with B. henselae and 23 (47 percent) with B. quintana. Subcutaneous and lytic bone lesions were strongly associated with B. quintana, whereas peliosis hepatis was associated exclusively with B. henselae. Patients with B. henselae infection were identified throughout the study period and were epidemiologically linked to cat and flea exposure (P< or =0.004), whereas those with B. quintana were clustered and were characterized by low income (P=0.003), homelessness (P = 0.004), and exposure to lice (P= 0.03). Prior treatment with macrolide antibiotics appeared to be protective against infection with either species.
CONCLUSIONS: B. henselae and B. quintana, the organisms that cause bacillary angiomatosis-peliosis, are associated with different epidemiologic risk factors and with predilections for involvement of different organs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407154     DOI: 10.1056/NEJM199712253372603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  55 in total

Review 1.  Natural history of Bartonella infections (an exception to Koch's postulate).

Authors:  V Jacomo; P J Kelly; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

2.  Recent Advances in Diagnosis and Treatment of Cat Scratch Disease.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

Review 3.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Bartonella henselae induces NF-kappaB-dependent upregulation of adhesion molecules in cultured human endothelial cells: possible role of outer membrane proteins as pathogenic factors.

Authors:  O Fuhrmann; M Arvand; A Göhler; M Schmid; M Krüll; S Hippenstiel; J Seybold; C Dehio; N Suttorp
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats: Implications for Feline Vaccine Development.

Authors:  Camille Huwyler; Nadja Heiniger; Bruno B Chomel; Minsoo Kim; Rickie W Kasten; Jane E Koehler
Journal:  Microb Ecol       Date:  2017-02-02       Impact factor: 4.552

6.  Clinical challenge: cutaneous Kaposi's sarcoma of the lower extremity.

Authors:  Erika L Johnson; Yvonne N Pierpont; Guillermo Donate; Mattew H Hiro; Rudolph J Mannari; Theodore J Strickland; Martin C Robson; Wyatt G Payne
Journal:  Int Wound J       Date:  2011-02-11       Impact factor: 3.315

7.  Body lice as tools for diagnosis and surveillance of reemerging diseases.

Authors:  V Roux; D Raoult
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Comparison of in-house and commercial slides for detection by immunofluorescence of immunoglobulins G and M against Bartonella henselae and Bartonella quintana.

Authors:  M Maurin; J M Rolain; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Bacillary angiomatosis in an HIV-positive man with multiple risk factors: A clinical and epidemiological puzzle.

Authors:  Farrah J Mateen; Jill C Newstead; Karen L McClean
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

10.  Bartonella quintana in body lice and head lice from homeless persons, San Francisco, California, USA.

Authors:  Denise L Bonilla; Hidenori Kabeya; Jennifer Henn; Vicki L Kramer; Michael Y Kosoy
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.